Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions.
Our primary focus is on developing novel drugs which we hope will help treat patients with certain blood cancers or solid tumors.
We have assembled a team of dedicated and highly-accomplished executives from across the biopharmaceutical industry to lead us in our pursuit of improving the lives of patients with cancer.
Careers at Karyopharm
As we continue to pursue our mission of improving the lives of patients with cancer, we plan to hire new employees across numerous functions.